Growth Restriction in Infants and Young Children with Congenital Heart Disease

Claire L Costello1, Marcelee Gellatly2, Jane Daniel2

  • 1Department of Nutrition & Dietetics, Mater Children's Hospital, Herston, Queensland, Australia.

Congenital Heart Disease
|November 12, 2014
PubMed

Insights

Growth restriction is common in children with congenital heart disease (CHD). Poor growth and feeding issues in these patients are linked to longer hospital stays, highlighting the need for early nutritional support.

Area of Science:

  • Pediatric Cardiology
  • Nutritional Science
  • Growth and Development

Background:

  • Congenital heart disease (CHD) affects numerous infants and children globally.
  • Growth restriction is a significant concern in pediatric populations with chronic conditions.
  • Understanding factors influencing growth in CHD is crucial for improving patient outcomes.

Purpose of the Study:

  • To determine the prevalence of growth restriction in infants and young children with CHD.
  • To investigate the relationship between poor growth, feeding difficulties, cardiac classification, and nutrition intervention.
  • To explore the impact of these factors on patient outcomes.

Main Methods:

  • Prospective observational cohort study involving 78 infants and young children (0-3 years) with CHD.
  • Data collection included anthropometry, growth history, cardiac classification, diagnosis, feeding difficulty, and nutrition intervention.
  • Participants were admitted to the hospital for cardiac surgery.

Main Results:

  • A significant prevalence of growth restriction was observed: 23% for weight/age, 21% for height/age, and 18% for weight/height (z-score ≤ -2).
  • Faltering growth preadmission, tube feeding requirements, cyanotic CHD diagnosis, and feeding difficulties were associated with increased hospital length of stay.
  • Statistical significance was noted for these associations (P values ranging from .002 to .015).

Conclusions:

  • Growth restriction is a persistent challenge in children with CHD.
  • Faltering growth and lower growth parameters correlate with prolonged hospital stays.
  • Early nutritional screening and intervention from diagnosis are recommended to improve outcomes for children with CHD.
Abstract

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.5K
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
23.1K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
943
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.7K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.2K